SCHEMBL24348798

SCHEMBL24348798

COc1nc(F)c(-c2ccc(F)cc2)c2sc(NC(=O)C3CCC(C)(O)CC3)nc12

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ACHE P22303 4/20 0.42
AHR P35869 1/20 0.40
ABL1 P00519 1/20 0.39
POLB P06746 1/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
GSK3B P49841 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29605867 0.84 ADORA2A (0.51) ADORA2AADORA2BADORA1
SCHEMBL24348815 0.73 HDAC2 (0.49) ADORA2AADORA2BADORA1
SCHEMBL31049913 0.69 TDP1 (0.38) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL24348830 0.69 MAPT (0.51) ALDH1A1MAPTTSHRHSD17B10AHR
SCHEMBL29605979 0.67 ALDH1A1 (0.49) ALDH1A1MAPTTSHRHSD17B10AHR
SCHEMBL24348240 0.67 MAPT (0.48) ALDH1A1MAPTTSHRHSD17B10AHR
SCHEMBL30128119 0.66 ADORA2A (0.44) ALDH1A1TSHRNPC1RAB9AADORA2A
SCHEMBL24348239 0.66 MAPT (0.47) ALDH1A1MAPTTSHRHSD17B10AHR
SCHEMBL29605460 0.66 ADORA1 (0.38) ALDH1A1MAPTHSD17B10POLBNPC1
SCHEMBL24348256 0.65 NPC1 (0.34) ALDH1A1MAPTHSD17B10POLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119412-A1 THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119412-A1 THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS ADORA1, ADORA2A, ADORA3 ALDH1A1 233/4885MAPT 4012/4885TSHR 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.